Physician profile
Carey E Coco
NPI 1407321300
$3,290.80
in general payments reported to CMS, 2019-2025
24 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $831 · 2022: $1,233 · 2023: $541 · 2024: $285 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $543.67 | 2021-2023 | Superion Indirect Decompression System |
| Merz North America, INC. | $485.80 | 2024-2025 | |
| Abbvie INC. | $473.86 | 2022-2023 | |
| Grt US Holding, INC. | $279.30 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $219.96 | 2021-2023 | Belbuca, Xtampza |
| Amgen INC. | $189.20 | 2021-2022 | |
| Medtronic, INC. | $182.39 | 2021-2023 | Intellis Adaptivestim |
| Revance Therapeutics, INC. | $160.75 | 2025 | Daxxify |
| Allergan, INC. | $113.84 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.50 | 2021-2022 | |
| Stimwave Technologies Incorporated | $86.78 | 2021-2022 | |
| Novo Nordisk INC | $84.04 | 2022 | |
| Nevro Corp. | $57.59 | 2022-2023 | Senza |
| Protega Pharmaceutials INC | $46.88 | 2023 | Roxybond |
| Ibsa Pharma INC. | $46.14 | 2023 | Tirosint, Licart |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $42.86 | 2022-2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $39.61 | 2025 | Proclaim |
| Relievant Medsystems, INC. | $39.56 | 2023 | Intracept |
| Averitas Pharma INC. | $21.04 | 2023 | Qutenza |
| Si-Bone, INC. | $19.14 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.84 | 2023 | |
| Biodelivery Sciences International, INC. | $14.30 | 2021 | |
| Painteq LLC | $14.20 | 2022 | |
| Fidia Pharma USA INC. | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carey Coco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.